ROIV

Roivant Sciences Ltd.

34.61^post+$0.02 (+0.06%)at close +$0.00 (+0.00%)

tap the star to start your desk

as of 19:59:59 UTCnext report Aug 17 · 12d

Earnings Room‹ back to ROIV

The report

fiscal Q1 2026 · from the company's notice

Aug 17before open12days out

Expected movement

market-implied · at the Aug 4 close

±8.1%is what the chain prices between now and the expiry below. Not a view we hold.

That span is 17days, so it covers the report plus the ordinary movement around it. The chain doesn't yet quote a second expiry we can separate the two with; the range narrows onto the report as it approaches.

expiry Aug 21 · first after the reportATM strike 35straddle 3.30ATM IV 55%× 0.85 straddle-to-rangespot 34.61

Blast radius

4 linked · N-PORT + EDGAR

If ROIV moves ±8.1% over this report, these carry part of it. Fund rows are arithmetic on published holding weights — what an index fund does by construction. Company rows are named by filings and their coefficient measured against two years of daily returns.

XBIfundState Street SPDR S&P Biotech ETF1.1% of the fund0.09%MDYfundState Street SPDR S&P MidCap 400SM ETF Trust0.39% of the fund0.03%VTIfundVanguard Total Stock Market Index Fund0.02% of the fund0.00%IMVTcustomerImmunovant, Inc.×0.97 · 500 days7.8%

Positioning

Butterfly Ladder

No options positioning captured for this ticker yet. Open interest settles once daily — check back after the next capture, or open this room again tomorrow.

The record

the session each report moved

The stamp starts filling with the next report we price. It pairs the move the options market expected with the move the stock actually made, so the multiple between them accumulates into this company's own record. Nothing is back-filled from figures we didn't observe.

2-quarter memory

Q3 FY25 · reported -0.38 · rev $2M

record note

The note composes when the report lands. Nothing is written for a quarter that hasn't been read.